Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor
2017-004466-98
Phase 1 small_molecule completed
Quick answer
Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor for Pain, Face is a Phase 1 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Pain, Face
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed